Colon CT scans might be able to prevent more colon cancers than stool DNA testing Two CT screening approaches outperformed stool DNA testing in computer models CT screening also was more ...

CHICAGO – New research reveals that computed tomography (CT) colonography, also known as virtual colonoscopy, has the potential to screen for two diseases at once—colorectal cancer and osteoporosis, ...

Computed tomographic (CT) colonography is used to examine the colon and rectum to detect abnormalities such as polyps and cancer. Polyps may be adenomatous (which have the potential to become ...

When performed every three to five years, CT colonographies may be more effective at catching instances of colon cancer than stool-based tests, according to a June 10 study published in Radiology. The ...

Compared to stool DNA testing, researchers found that CT colonography is a cost-saving and clinically effective method for colorectal cancer screening, according to a study was published today in ...

Undertaking both PET and CT scans during a single examination (PET/CT) permits more accurate functional and morphological imaging than either technique alone. German researchers, therefore, developed ...

Images of positive CT colonography (CTC) screening examination result in an asymptomatic 67-year-old man. Three-dimensional colon map from CTC (left image) shows the location of two sigmoid polyps ...

CT colonography reduced the incidence of colorectal cancer by up to 75% versus no screening, while stool DNA testing reduced the incidence by 59%. Stool testing was cost-effective relative to no ...

Colonography comprising a combined modality of PET and CT (PET–;CT) could shorten the multimodality diagnostic work-up required for the conventional staging of patients with colorectal cancer. In a ...

Treatment intensification by induction chemotherapy (ICT) and radiation dose escalation in locally advanced squamous cell anal canal carcinoma (LAAC): Definitive analysis of the intergroup ACCORD 03 ...

Factors modulating worry and risk perception of breast cancer in a prevention trial of low dose tamoxifen in postmenopausal hormone users.